Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Dec 24, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | A | A | $52.67B | 132,113,818 | 82.79% | 17.21% | Net Selling | Net Selling |
| ONC | BEONE MEDICINES LTD | A | A | $34.60B | 1,438,553,263 | 2.29% | 32.02% | Net Buying | Net Selling |
| FIX | COMFORT SYSTEMS USA INC | A | B | $34.05B | 35,271,950 | 94.43% | 3.87% | Net Selling | Net Selling |
| NVT | NVENT ELECTRIC PLC | A | B | $16.78B | 161,359,550 | 90.40% | 9.60% | Net Selling | Net Buying |
| NBIX | NEUROCRINE BIOSCIENCES INC | A | B | $14.68B | 99,705,698 | 70.78% | 29.22% | Net Selling | Net Buying |
| VTRS | VIATRIS INC | A | C | $13.84B | 1,151,769,872 | 81.80% | 18.20% | Net Selling | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | A | C | $10.30B | 60,765,116 | 28.42% | 71.58% | Net Selling | Net Selling |
| SGHC | SUPER GROUP (SGHC) LTD | A | B | $6.05B | 505,728,590 | 15.36% | 0.00% | ||
| GTES | GATES INDUSTRIAL CORP PLC | A | C | $5.73B | 258,280,391 | 89.11% | 10.89% | Net Buying | Net Selling |
| CPA | COPA HOLDINGS SA | A | B | $5.02B | 41,172,956 | 65.77% | 0.00% | ||
| UGP | ULTRAPAR HOLDINGS INC | A | B | $4.03B | 1,082,072,593 | 4.95% | 0.00% | ||
| CALX | CALIX INC | A | A | $3.67B | 66,276,473 | 77.48% | 22.52% | Net Selling | Net Selling |
| SPNT | SIRIUSPOINT LTD | A | A | $2.62B | 116,814,640 | 64.36% | 35.64% | Net Selling | |
| HCI | HCI GROUP INC | A | B | $2.54B | 12,960,037 | 78.69% | 9.80% | Net Selling | |
| EXTR | EXTREME NETWORKS INC | A | B | $2.24B | 133,718,479 | 82.39% | 17.61% | Net Selling | Net Selling |
| ANIP | ANI PHARMACEUTICALS INC | A | B | $1.81B | 22,469,032 | 29.82% | 70.18% | Net Selling | Net Selling |
| BLBD | BLUE BIRD CORP | A | B | $1.65B | 31,714,959 | 67.97% | 32.03% | Net Selling | Net Selling |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | B | $1.59B | 210,543,224 | 83.67% | 16.33% | Net Selling | Net Selling |
| DNOW | DNOW INC | A | B | $1.43B | 105,011,966 | 96.58% | 3.42% | Net Selling | |
| ANAB | ANAPTYSBIO INC | A | B | $1.39B | 27,688,470 | 42.70% | 57.30% | Net Buying | Net Selling |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | A | B | $1.23B | 26,537,083 | 75.68% | 24.32% | Net Selling | |
| TBLA | TABOOLACOM LTD | A | A | $1.20B | 288,223,366 | 29.76% | 28.29% | Net Selling | Net Selling |
| NUTX | NUTEX HEALTH INC | A | B | $1.18B | 7,071,916 | 0.14% | 99.86% | Net Selling | Net Buying |
| CRTO | CRITEO SA | A | A | $1.07B | 52,549,158 | 84.84% | 11.89% | Net Selling | Net Buying |
| TBPH | THERAVANCE BIOPHARMA INC | A | B | $940.99M | 50,672,431 | 52.91% | 47.09% | Net Selling | Net Selling |
| ORGO | ORGANOGENESIS HOLDINGS INC | A | A | $729.74M | 126,912,142 | 6.93% | 93.07% | Net Selling | Net Selling |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | A | C | $515.71M | 37,316,546 | 13.00% | 0.00% | ||
| VREX | VAREX IMAGING CORP | A | A | $502.90M | 41,700,000 | 93.34% | 1.83% | Net Selling | Net Selling |
| LE | LANDS' END INC | A | C | $434.44M | 30,551,068 | 13.36% | 86.64% | Net Selling | Net Selling |
| EGHT | 8X8 INC | A | B | $273.12M | 138,640,363 | 70.05% | 29.95% | Net Selling | Net Selling |
| OPRX | OPTIMIZERX CORP | A | B | $237.48M | 18,640,652 | 52.15% | 47.85% | Net Buying | Net Selling |
| ELMD | ELECTROMED INC | A | A | $228.11M | 8,340,538 | 31.32% | 68.68% | Net Selling | |
| LTRX | LANTRONIX INC | A | B | $226.31M | 39,358,610 | 7.46% | 92.54% | Net Selling | Net Selling |
| CXDO | CREXENDO INC | A | A | $202.82M | 30,731,048 | 25.99% | 48.85% | Net Selling | Net Selling |
| INFU | INFUSYSTEM HOLDINGS INC | A | A | $183.84M | 20,336,183 | 25.27% | 74.73% | Net Selling | Net Selling |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.